Mixed Glioma

9 clinical trials · Condition

Record	Firm	Date
Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas (NCT02976441)	Washington University School of Medicine	2017-01-01
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma (NCT02101905)	National Cancer Institute (NCI)	2016-11-07
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors (NCT02372409)	Washington University School of Medicine	2015-08-14
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas (NCT02238496)	Andrew B Lassman, MD	2014-12-08
Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma (NCT01250470)	Roswell Park Cancer Institute	2012-09-05
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 (NCT01082926)	City of Hope Medical Center	2010-05-01
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma (NCT01095094)	Case Comprehensive Cancer Center	2009-01-01
Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme (NCT00390299)	Mayo Clinic	2006-10-23
Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors (NCT00303849)	OHSU Knight Cancer Institute	2005-09-15

Track Mixed Glioma automatically

Every clearance here is in the API, with alerts when new ones post.